FTC Detects Cancer Screening Monopoly
The Federal Trade Commission filed a complaint Friday against Hologic Inc., saying the medical device maker's $32 million purchase of rival Fischer Imaging Corp.'s breast cancer screening business would harm consumers...To view the full article, register now.
Already a subscriber? Click here to view full article